Enhanced COVID-19 Transparency Act of 2025
- Sponsor
- Sen. Young, Todd [R-IN]
- Committees
- Intelligence (Select) Committee (primary)
- Last action
- Dec 1, 2025
Bottom line
This bill aims to increase public transparency regarding the intelligence community's understanding of the COVID-19 pandemic's origins and the Chinese government's actions related to it through a mandated declassification and public release of intelligence.
What it actually does
This bill mandates the Director of National Intelligence and the heads of intelligence community elements to conduct a declassification review of intelligence products related to the origins of the Coronavirus Disease 2019 (COVID-19), including research at the Wuhan Institute of Virology, gain-of-function research, and funding sources. It also requires a review of intelligence concerning efforts by Chinese government officials to disrupt information sharing, obstruct investigations, or promote alternative narratives regarding the pandemic. The declassified information must be made public, with necessary redactions, and an unredacted version submitted to congressional intelligence committees.
Proponents argue
Supporters argue that this bill is crucial for public understanding of the pandemic's origins, holding the Chinese government accountable for any obstruction, and informing future pandemic preparedness strategies. They believe that increased transparency builds public trust and allows for more robust scientific and policy responses to global health crises.
Opponents contend
Opponents might argue that declassifying sensitive intelligence, even with redactions, could compromise intelligence sources and methods, potentially harming national security or future intelligence gathering capabilities. They may also contend that such a review could be politicized or lead to the release of inconclusive or misinterpreted information, potentially causing unnecessary international tensions.
The bill is very short and straightforward, making it highly accessible for readers to understand its core purpose and provisions.
Section 2(b)(1)
Declassification Review of COVID-19 Origins Intelligence
This provision requires the Director of National Intelligence and the heads of intelligence community elements to perform a declassification review of intelligence products related to the origins of COVID-19. This includes information on research conducted at the Wuhan Institute of Virology or other Chinese medical/scientific centers, details regarding Gain of Function research and its intent, and intelligence on sources of funding or direction for coronavirus research, both within China and from foreign entities.
Supporters argue
Supporters argue that this provision is essential for transparency, allowing the public and scientific community to better understand how the pandemic began. They believe it can help prevent future pandemics, inform public health policy, and hold responsible parties accountable.
Critics contend
Critics might express concern that declassifying intelligence, even with redactions, could inadvertently reveal sensitive sources and methods, potentially jeopardizing future intelligence gathering capabilities. They may also argue that the information, if inconclusive, could fuel misinformation or unhelpful speculation.
Tradeoffs
This provision balances the public's right to know and the need for government transparency against the imperative to protect national security intelligence sources and methods.
Section 2(b)(2)
Declassification Review of Chinese Obstruction Efforts
This section mandates a declassification review of intelligence concerning efforts by officials of the People's Republic of China to disrupt or obstruct information sharing or investigations into COVID-19 origins. This includes actions to limit sharing of medically significant information, obstruct data flow within China and with external researchers, deny information to the US and allies, pressure foreign entities, disrupt medical research and development, and promote alternative narratives about the pandemic.
Section 2(b)(3) and 2(b)(4)
Public Release and Congressional Submission of Declassified Intelligence
This provision requires the Director of National Intelligence to make the declassified intelligence products described in the previous sections publicly available. It allows for redactions deemed necessary to protect sources, methods, and information concerning United States persons. Additionally, an unredacted version of these declassified products must be submitted to the congressional intelligence committees within the same 180-day timeframe.